This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Avi Kapoor 7 months ago
NewsUpgradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised price targets. See analyst ratings page.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Mizuho analyst Uy Ear upgraded Uniqure NV (NASDAQ:QURE) from Neutral to Outperform and raised the price target from $12 to $35. uniQure shares closed at $18.26 on Tuesday. See how other analysts view this stock.
- BTIG analyst Sam Eiber upgraded Apyx Medical Inc (NASDAQ:APYX) from Neutral to Buy and announced a $6 price target. Apyx Medical shares closed at $3.45 on Tuesday. See how other analysts view this stock.
- Bernstein analyst Alexia Howard upgraded J M Smucker Co (NYSE:SJM) from Market Perform to Outperform and boosted the price target from $121 to $145. JM Smucker shares closed at $108.47 on Tuesday. See how other analysts view this stock.
- Banco Bradesco BBI S.A analyst Daniel Federle upgraded VTEX (NYSE:VTEX) from Neutral to Outperform and announced a $5 price target. Vtex shares closed at $4.05 on Tuesday. See how other analysts view this stock.
Considering buying SJM stock? Here’s what analysts think:
Photo via Shutterstock